Chong Kun Dang Pharmaceutical Free Cash Flow Generation Index
Chong Kun Dang Pharmaceutical free cash flow generation index. Chong Kun Dang Pharmaceutical (185750) has a Free Cash Flow Generation Index of -5.04x as of March 2026. Free cash flow of ₩-62.02 Billion represents -5% of operating cash flow (₩12.32 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Chong Kun Dang Pharmaceutical (2016–2025)
Free cash flow generation index of Chong Kun Dang Pharmaceutical from 2016 to 2025. Historical FCF Generation Index trend for Chong Kun Dang Pharmaceutical across 10 annual periods. See Chong Kun Dang Pharmaceutical (185750) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Chong Kun Dang Pharmaceutical Free Cash Flow Generation Index by Year (2016–2025)
Chong Kun Dang Pharmaceutical free cash flow generation index by year from 2016 to 2025. Year-by-year Free Cash Flow Generation Index for Chong Kun Dang Pharmaceutical. For the full cash flow conversion analysis, see 185750 cash generation efficiency.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.66x | ₩-111.77 Billion | ₩67.36 Billion | ₩179.13 Billion | ▼ -5783.4% |
| 2024 | -0.03x | ₩-1.81 Billion | ₩64.29 Billion | ₩66.10 Billion | ▼ -103.6% |
| 2023 | 0.78x | ₩249.35 Billion | ₩318.16 Billion | ₩68.81 Billion | ▲ +261.9% |
| 2022 | 0.22x | ₩14.67 Billion | ₩67.73 Billion | ₩44.90 Billion | ▲ +107.2% |
| 2021 | -3.02x | ₩-38.94 Billion | ₩12.90 Billion | ₩48.24 Billion | ▼ -566.4% |
| 2020 | 0.65x | ₩67.51 Billion | ₩104.32 Billion | ₩32.64 Billion | ▼ -4.6% |
| 2019 | 0.68x | ₩52.43 Billion | ₩77.29 Billion | ₩21.84 Billion | ▲ +60.8% |
| 2018 | 0.42x | ₩17.99 Billion | ₩42.63 Billion | ₩21.92 Billion | ▼ -42.9% |
| 2017 | 0.74x | ₩60.35 Billion | ₩81.67 Billion | ₩19.79 Billion | ▼ -56.1% |
| 2016 | 1.68x | ₩97.23 Billion | ₩57.79 Billion | ₩39.44 Billion | — |